Authors : Rejina C.; Dr. A. Pandiselvi; HarishKumar E.; SaranKarthikeyan S.

Volume/Issue : Volume 10 - 2025, Issue 8 - August

Google Scholar : https://tinyurl.com/4ce82ysu

Scribd : https://tinyurl.com/6cb24css

DOI : https://doi.org/10.38124/ijisrt/25aug1101

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.

Note : Google Scholar may take 30 to 40 days to display the article.

Abstract : Inflammation serves as both a stimulus for bone regeneration and a driver of deterioration. Although the process of bone remodelling is strictly regulated by osteoblasts, osteoclasts, osteocytes, and bone-lining cells, immunological signalling significantly affects how it is balanced. Acute inflammation is crucial for initiating bone repair because cytokines such as IL-1, IL-6, and TNF-α draw neutrophils and macrophages to the fracture site, clear debris, and encourage mesenchymal stem cell differentiation into osteoblasts. However, prolonged or dysregulated inflammation promotes bone loss by tilting the RANKL/OPG axis in favour of osteoclastogenesis, a characteristic of diseases such as inflammatory bowel disease, periodontitis, and rheumatoid arthritis. The new field of osteoimmunology shows how immune cells have two different effects: Th17 cells, hyperactivated neutrophils, and pro-inflammatory macrophages speed up bone resorption, while Tregs, osteomacs, and B cell-derived OPG encourage regeneration. This review emphasises how inflammation's temporal, cellular, and molecular context determines skeletal outcomes, highlighting the thin line separating repair from ruin. Comprehending this osteoimmune paradox offers therapeutic options, such as immune cell reprogramming, cytokine modulation, and RANKL inhibition, to promote bone regeneration while reducing inflammation-induced bone loss.

Keywords : Inflammation, Bone Remodelling, Osteoimmunology, Osteoclastogenesis, RANKL/OPG Axis, Cytokines, T Regulatory Cells, Th17 Cells, Osteomacs, Bone Regeneration.

References :

1. Eddouks M, Chattopadhyay D, Zeggwagh NA. Animal models as tools to investigate antidiabetic and anti‐inflammatory plants. Evidence‐based Complementary and Alternative Medicine. 2012;2012(1):142087.
2. Calixto JB, Otuki MF, Santos AR. Anti-inflammatory compounds of plant origin. Part I. Action on arachidonic acid pathway, nitric oxide and nuclear factor κ B (NF-κb). Planta medica. 2003 Nov;69(11):973-83.
3. Kulkarni RG, Achaiah G, Narahari Sastry G. Novel targets for antiinflammatory and antiarthritic agents. Current pharmaceutical design. 2006 Jul 1;12(19):2437-54.
4. Nathan C, Ding A. Nonresolving inflammation. Cell. 2010 Mar 19;140(6):871-82.
5. Rossi JF, Lu ZY, Massart C, Levon K. Dynamic immune/inflammation precision medicine: the good and the bad inflammation in infection and cancer. Front Immunol. 2021; 12: 595722. Rheumatology Quarterly. 2023;1(4):157-61.
6. Plytycz B, Seljelid R. From inflammation to sickness: historical perspective. Archiwum Immunologiae et Therapiae Experimentalis. 2003 Jan 1;51(2):105-10.
7. Parfitt AM. Osteonal and hemi‐osteonal remodeling: The spatial and temporal framework for signal traffic in adult human bone. Journal of cellular biochemistry. 1994 Jul;55(3):273-86.
8. Seeman E. Bone modeling and remodeling. Critical Reviews™ in Eukaryotic Gene Expression. 2009;19(3).
9. Teitelbaum SL. Bone resorption by osteoclasts. Science. 2000 Sep 1;289(5484):1504-8.
10. Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature. 2003 May 15;423(6937):337-42.
11. Ducy P, Schinke T, Karsenty G. The osteoblast: a sophisticated fibroblast under central surveillance. Science. 2000 Sep 1;289(5484):1501-4.
12. Walters G, Pountos I, Giannoudis PV. The cytokines and micro‐environment of fracture haematoma: Current evidence. J Tissue Eng Regen Med [Internet]. 2018 Mar [cited 2025 Feb 14];12(3). Available from: https://onlinelibrary.wiley.com/doi/10.1002/term.2593
13. Copuroglu C, Calori GM, Giannoudis PV. Fracture non-union: Who is at risk? Injury. 2013 Nov;44(11):1379–82.
14. Foulke BA, Kendal AR, Murray DW, Pandit H. Fracture healing in the elderly: A review. Maturitas. 2016 Oct; 92:49–55.
15. Bastian O, Pillay J, Alblas J, Leenen L, Koenderman L, Blokhuis T. Systemic inflammation and fracture healing. J Leukoc Biol. 2011 Jan 4;89(5):669–73.
16. Fullerton JN, Gilroy DW. Resolution of inflammation: a new therapeutic frontier. Nat Rev Drug Discov. 2016 Aug;15(8):551–67.
17. Batoon L, Millard SM, Raggatt LJ, Pettit AR. Osteomacs and Bone Regeneration. Curr Osteoporos Rep. 2017 Aug;15(4):385–95.
18. Miron RJ, Bosshardt DD. OsteoMacs: Key players around bone biomaterials. Biomaterials. 2016 Mar; 82:1–19.
19. Hardy R, Cooper MS. Bone loss in inflammatory disorders. Journal of Endocrinology. 2009 Jun 1;201(3):309-20.
20. Thomson BM, Mundy GR, Chambers TJ. Tumor necrosis factors alpha and beta induce osteoblastic cells to stimulate osteoclastic bone resorption. Journal of immunology (Baltimore, Md.: 1950). 1987 Feb 1;138(3):775-9.
21. Kobayashi K, Takahashi N, Jimi E, Udagawa N, Takami M, Kotake S, Nakagawa N, Kinosaki M, Yamaguchi K, Shima N, Yasuda H. Tumor necrosis factor α stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL–RANK interaction. The Journal of experimental medicine. 2000 Jan 17;191(2):275-86.
22. Kim N, Kadono Y, Takami M, Lee J, Lee SH, Okada F, Kim JH, Kobayashi T, Odgren PR, Nakano H, Yeh WC. Osteoclast differentiation independent of the TRANCE–RANK–TRAF6 axis. The Journal of experimental medicine. 2005 Sep 5;202(5):589-95.
23. Kong YY, Feige U, Sarosi I, Bolon B, Tafuri A, Morony S, Capparelli C, Li J, Elliott R, McCabe S, Wong T. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature. 1999 Nov 18;402(6759):304-9.
24. Gravallese EM, Manning C, Tsay A, Naito A, Pan C, Amento E, Goldring SR. Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor. Arthritis & Rheumatism: Official Journal of the American College of Rheumatology. 2000 Feb;43(2):250-8.
25. Kotake S, Udagawa N, Hakoda M, Mogi M, Yano K, Tsuda E, Takahashi K, Furuya T, Ishiyama S, Kim KJ, Saito S. Activated human T cells directly induce osteoclastogenesis from human monocytes: possible role of T cells in bone destruction in rheumatoid arthritis patients. Arthritis & Rheumatism: Official Journal of the American College of Rheumatology. 2001 May;44(5):1003-12.
26. Ono T, Takayanagi H. Osteoimmunology in bone fracture healing. Current osteoporosis reports. 2017 Aug; 15:367-75.
27. Kolaczkowska E, Kubes P. Neutrophil recruitment and function in health and inflammation. Nature reviews immunology. 2013 Mar;13(3):159-75.
28. Kovtun A, Bergdolt S, Wiegner R, Radermacher P, Huber-Lang M, Ignatius A. The crucial role of neutrophil granulocytes in bone fracture healing. Eur Cell Mater. 2016 Jul 25; 32:152-62.
29. Poubelle PE, Chakravarti A, Fernandes MJ, Doiron K, Marceau AA. Differential expression of RANK, RANK-L, and osteoprotegerin by synovial fluid neutrophils from patients with rheumatoid arthritis and by healthy human blood neutrophils. Arthritis research & therapy. 2007 Apr; 9:1-2.
30. Chakravarti A, Raquil MA, Tessier P, Poubelle PE. Surface RANKL of Toll-like receptor 4–stimulated human neutrophils activates osteoclastic bone resorption. Blood, The Journal of the American Society of Hematology. 2009 Aug 20;114(8):1633-44.
31. Del Fabbro M, Francetti L, Pizzoni L, Rozza R, Weinstein RL. Neutrophil physiology: role and mechanism of action in the immune response at gingival level. Minerva stomatologica. 2000 May 1;49(5):227-48.
32. Karlmark K, Tacke F, Dunay I. Monocytes in health and disease—Minireview. European Journal of Microbiology and Immunology. 2012 Jun 1;2(2):97-102.
33. Murray PJ, Allen JE, Biswas SK, Fisher EA, Gilroy DW, Goerdt S, Gordon S, Hamilton JA, Ivashkiv LB, Lawrence T, Locati M. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity. 2014 Jul 17;41(1):14-20.
34. Kong L, Wang Y, Smith W, Hao D. Macrophages in bone homeostasis. Current stem cell research & therapy. 2019 Aug 1;14(6):474-81.
35. Rossi M, Young JW. Human dendritic cells: potent antigen-presenting cells at the crossroads of innate and adaptive immunity. The Journal of Immunology. 2005 Aug 1;175(3):1373-81.
36. Liu K, Nussenzweig MC. Origin and development of dendritic cells. Immunological reviews. 2010 Mar;234(1):45-54.
37. Rehaume LM, Hancock RE. Neutrophil-derived defensins as modulators of innate immune function. Critical Reviews™ in Immunology. 2008;28(3).
38. Reeves EP, Lu H, Jacobs HL, Messina CG, Bolsover S, Gabella G, Potma EO, Warley A, Roes J, Segal AW. Killing activity of neutrophils is mediated through activation of proteases by K+ flux. Nature. 2002 Mar 21;416(6878):291-7.
39. Nauseef WM. How human neutrophils kill and degrade microbes: an integrated view. Immunological reviews. 2007 Oct;219(1):88-102.
40. Fox S, Leitch AE, Duffin R, Haslett C, Rossi AG. Neutrophil apoptosis: relevance to the innate immune response and inflammatory disease. Journal of innate immunity. 2010 Feb 11;2(3):216-27.
41. DM M. The many faces of macrophage activation. J Leukoc Biol. 2003; 73:209-12.
42. Verreck FA, de Boer T, Langenberg DM, van der Zanden L, Ottenhoff TH. Phenotypic and functional profiling of human proinflammatory type-1 and anti-inflammatory type-2 macrophages in response to microbial antigens and IFN-γ-and CD40L-mediated costimulation. Journal of leukocyte biology. 2006 Feb;79(2):285-93.
43. Aarden EM, Nijweide PJ, Burger EH. Function of osteocytes in bone. Journal of cellular biochemistry. 1994 Jul;55(3):287-99.
44. Gordon S. Elie Metchnikoff, the man and the myth. Journal of innate immunity. 2016 Apr 1;8(3):223-7.
45. Wang S, Xiao L, Prasadam I, Crawford R, Zhou Y, Xiao Y. Inflammatory macrophages interrupt osteocyte maturation and mineralization via regulating the Notch signaling pathway. Molecular Medicine. 2022 Dec;28(1):102.
46. Horowitz MC, Fretz JA, Lorenzo JA. How B cells influence bone biology in health and disease. Bone. 2010 Sep 1;47(3):472-9.
47. Zhang Y, Ma C, Liu C, Wu W. NF-κB promotes osteoclast differentiation by overexpressing MITF via down regulating microRNA-1276 expression. Life Sciences. 2020 Oct 1; 258:118093.
48. Ratajczak MZ, Zuba-Surma EK, Wojakowski W, Ratajczak J, Kucia M. Bone marrow–home of versatile stem cells. Transfusion Medicine and Hemotherapy. 2008 May 8;35(3):248-59.
49. Karsenty G, Wagner EF. Reaching a genetic and molecular understanding of skeletal development. Developmental cell. 2002 Apr 1;2(4):389-406.
50. Könnecke I, Serra A, El Khassawna T, Schlundt C, Schell H, Hauser A, Ellinghaus A, Volk HD, Radbruch A, Duda GN, Schmidt-Bleek K. T and B cells participate in bone repair by infiltrating the fracture callus in a two-wave fashion. Bone. 2014 Jul 1; 64:155-65.
51. Ramirez K, Witherden DA, Havran WL. All hands-on DE (T) C: Epithelial-resident γδ T cells respond to tissue injury. Cellular immunology. 2015 Jul 1;296(1):57-61.
52. Ono T, Okamoto K, Nakashima T, Nitta T, Hori S, Iwakura Y, Takayanagi H. IL-17-producing γδ T cells enhance bone regeneration. Nature communications. 2016 Mar 11;7(1):10928.
53. Zhu J, Paul WE. CD4 T cells: fates, functions, and faults. Blood, The Journal of the American Society of Hematology. 2008 Sep 1;112(5):1557-69.
54. Lai LW, Yong KC, Lien YH. Pharmacologic recruitment of regulatory T cells as a therapy for ischemic acute kidney injury. Kidney international. 2012 May 2;81(10):983-92.
55. Sato K, Suematsu A, Okamoto K, Yamaguchi A, Morishita Y, Kadono Y, Tanaka S, Kodama T, Akira S, Iwakura Y, Cua DJ. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. Journal of experimental medicine. 2006 Nov 27;203(12):2673-82.
56. Liu Y, Wang L, Kikuiri T, Akiyama K, Chen C, Xu X, Yang R, Chen W, Wang S, Shi S. Mesenchymal stem cell–based tissue regeneration is governed by recipient T lymphocytes via IFN-γ and TNF-α. Nature medicine. 2011 Dec;17(12):1594-601.
57. Liu Y, Wang L, Liu S, Liu D, Chen C, Xu X, Chen X, Shi S. Transplantation of SHED prevents bone loss in the early phase of ovariectomy-induced osteoporosis. Journal of Dental Research. 2014 Nov;93(11):1124-32.
58. Zaiss MM, Frey B, Hess A, Zwerina J, Luther J, Nimmerjahn F, Engelke K, Kollias G, Hünig T, Schett G, David JP. Regulatory T cells protect from local and systemic bone destruction in arthritis. The Journal of Immunology. 2010 Jun 15;184(12):7238-46.
59. Liu Y, Wang L, Kikuiri T, Akiyama K, Chen C, Xu X, Yang R, Chen W, Wang S, Shi S. Mesenchymal stem cell–based tissue regeneration is governed by recipient T lymphocytes via IFN-γ and TNF-α. Nature medicine. 2011 Dec;17(12):1594-601.
60. Murphy TJ, Choileain NN, Zang Y, Mannick JA, Lederer JA. CD4+ CD25+ regulatory T cells control innate immune reactivity after injury. The Journal of Immunology. 2005 Mar 1;174(5):2957-63.
61. Lavine KJ, Epelman S, Uchida K, Weber KJ, Nichols CG, Schilling JD, Ornitz DM, Randolph GJ, Mann DL. Distinct macrophage lineages contribute to disparate patterns of cardiac recovery and remodeling in the neonatal and adult heart. Proceedings of the National Academy of Sciences. 2014 Nov 11;111(45):16029-34.
62. Aurora AB, Porrello ER, Tan W, Mahmoud AI, Hill JA, Bassel-Duby R, Sadek HA, Olson EN. Macrophages are required for neonatal heart regeneration. The Journal of clinical investigation. 2014 Mar 3;124(3):1382-92.
63. Liu Y, Wang L, Kikuiri T, Akiyama K, Chen C, Xu X, Yang R, Chen W, Wang S, Shi S. Mesenchymal stem cell–based tissue regeneration is governed by recipient T lymphocytes via IFN-γ and TNF-α. Nature medicine. 2011 Dec;17(12):1594-601.
64. Kovtun A, Bergdolt S, Wiegner R, Radermacher P, Huber-Lang M, Ignatius A. The crucial role of neutrophil granulocytes in bone fracture healing. Eur Cell Mater. 2016 Jul 25; 32:152-62.
65. Chakravarti A, Raquil MA, Tessier P, Poubelle PE. Surface RANKL of Toll-like receptor 4–stimulated human neutrophils activates osteoclastic bone resorption. Blood, The Journal of the American Society of Hematology. 2009 Aug 20;114(8):1633-44.
66. Kanamaru F, Iwai H, Ikeda T, Nakajima A, Ishikawa I, Azuma M. Expression of membrane-bound and soluble receptor activator of NF-κB ligand (RANKL) in human T cells. Immunology letters. 2004 Jul 15;94(3):239-46.
67. Allaeys I, Rusu D, Picard S, Pouliot M, Borgeat P, Poubelle PE. Osteoblast retraction induced by adherent neutrophils promotes osteoclast bone resorption: implication for altered bone remodeling in chronic gout. Laboratory Investigation.
68. Allaeys I, Rusu D, Picard S, Pouliot M, Borgeat P, Poubelle PE. Osteoblast retraction induced by adherent neutrophils promotes osteoclast bone resorption: implication for altered bone remodeling in chronic gout. Laboratory Investigation. 2011 Jun 1;91(6):905-20.
69. Schlundt C, El Khassawna T, Serra A, Dienelt A, Wendler S, Schell H, van Rooijen N, Radbruch A, Lucius R, Hartmann S, Duda GN. Macrophages in bone fracture healing: their essential role in endochondral ossification. Bone. 2018 Jan 1; 106:78-89.
70. Schmidt-Bleek K, Schell H, Kolar P, et al. Cellular composition of the initial fracture hematoma compared to a muscle hematoma: A study in sheep. J Orthop Res. 2009; 27: 1147-1151.
71. Shen Y, Zhang Y, Zhou Z, Wang J, Han D, Sun J, Chen G, Tang Q, Sun W, Chen L. Dysfunction of macrophages leads to diabetic bone regeneration deficiency. Frontiers in Immunology. 2022 Oct 14; 13:990457.
72. Galván-Peña S, O’Neill LA. Metabolic reprograming in macrophage polarization. Frontiers in immunology. 2014 Sep 2; 5:420.
73. Jiao H, Xiao E, Graves DT. Diabetes and its effect on bone and fracture healing. Current osteoporosis reports. 2015 Oct; 13:327-35.
74. Vannella KM, Wynn TA. Mechanisms of organ injury and repair by macrophages. Annual review of physiology. 2017 Feb 10;79(1):593-617.
75. Culemann S, Grüneboom A, Nicolás-Ávila JÁ, Weidner D, Lämmle KF, Rothe T, Quintana JA, Kirchner P, Krljanac B, Eberhardt M, Ferrazzi F. Locally renewing resident synovial macrophages provide a protective barrier for the joint. Nature. 2019 Aug 29;572(7771):670-5.
76. Collin M, Bigley V. Human dendritic cell subsets: an update. Immunology. 2018 May;154(1):3-20.
77. Miyamoto T, Ohneda O, Arai F, Iwamoto K, Okada S, Takagi K, Anderson DM, Suda T. Bifurcation of osteoclasts and dendritic cells from common progenitors. Blood, The Journal of the American Society of Hematology. 2001 Oct 15;98(8):2544-54.
78. Steinman RM, Banchereau J. Taking dendritic cells into medicine. Nature. 2007 Sep 27;449(7161):419-26.
79. McKenna HJ, Stocking KL, Miller RE, Brasel K, De Smedt T, Maraskovsky E, Maliszewski CR, Lynch DH, Smith J, Pulendran B, Roux ER. Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells. Blood, The Journal of the American Society of Hematology. 2000 Jun 1;95(11):3489-97.
80. McKenna HJ, Stocking KL, Miller RE, Brasel K, De Smedt T, Maraskovsky E, Maliszewski CR, Lynch DH, Smith J, Pulendran B, Roux ER. Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells. Blood, The Journal of the American Society of Hematology. 2000 Jun 1;95(11):3489-97.
81. Page G, Miossec P. RANK and RANKL expression as markers of dendritic cell–T cell interactions in paired samples of rheumatoid synovium and lymph nodes. Arthritis & Rheumatism: Official Journal of the American College of Rheumatology. 2005 Aug;52(8):2307-12.
82. Cirrincione C, Pimpinelli N, Orlando L, Romagnoli P. Lamina propria dendritic cells express activation markers and contact lymphocytes in chronic periodontitis. Journal of periodontology. 2002 Jan;73(1):45-52.
83. Miyamoto T, Ohneda O, Arai F, Iwamoto K, Okada S, Takagi K, Anderson DM, Suda T. Bifurcation of osteoclasts and dendritic cells from common progenitors. Blood, The Journal of the American Society of Hematology. 2001 Oct 15;98(8):2544-54.
84. Yang M, Zhu L. Osteoimmunology: the crosstalk between T cells, B cells, and osteoclasts in rheumatoid arthritis. International Journal of Molecular Sciences. 2024 Feb 26;25(5):2688.
85. Panez-Toro I, Heymann D, Gouin F, Amiaud J, Heymann MF, Cordova LA. Roles of inflammatory cell infiltrate in periprosthetic osteolysis. Frontiers in Immunology. 2023 Dec 1; 14:1310262.
86. Zeng W, Liu G, Luan Q, Yang C, Li S, Yu X, Su L. B-cell deficiency exacerbates inflammation and bone loss in ligature-induced experimental periodontitis in mice. Journal of Inflammation Research. 2021 Oct 15:5367-80.
87. Chen Y, Wang H, Ni Q, Wang T, Bao C, Geng Y, Lu Y, Cao Y, Li Y, Li L, Xu Y. B-cell–derived TGF-β1 inhibits osteogenesis and contributes to bone loss in periodontitis. Journal of Dental Research. 2023 Jul;102(7):767-76.
88. Liu Y, Wang L, Kikuiri T, Akiyama K, Chen C, Xu X, Yang R, Chen W, Wang S, Shi S. Mesenchymal stem cell–based tissue regeneration is governed by recipient T lymphocytes via IFN-γ and TNF-α. Nature medicine. 2011 Dec;17(12):1594-601.
89. Sato K, Suematsu A, Okamoto K, Yamaguchi A, Morishita Y, Kadono Y, Tanaka S, Kodama T, Akira S, Iwakura Y, Cua DJ. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. Journal of experimental medicine. 2006 Nov 27;203(12):2673-82.
90. Hirayama T, Dai S, Abbas S, Yamanaka Y, Abu‐Amer Y. Inhibition of inflammatory bone erosion by constitutively active STAT‐6 through blockade of JNK and NF‐κB activation. Arthritis & Rheumatism. 2005 Sep;52(9):2719-29.
91. Choi Y, Mi Woo K, Ko SH, Jung Lee Y, Park SJ, Kim HM, Kwon BS. Osteoclastogenesis is enhanced by activated B cells but suppressed by activated CD8+ T cells. European journal of immunology. 2001 Jul;31(7):2179-88.
92. Noonan K, Marchionni L, Anderson J, Pardoll D, Roodman GD, Borrello I. A novel role of IL-17–producing lymphocytes in mediating lytic bone disease in multiple myeloma. Blood, The Journal of the American Society of Hematology. 2010 Nov 4;116(18):3554-63.
93. Halvorsen EH, Strønen E, Hammer HB, Goll GL, Sollid LM, Molberg Ø. Interleukin‐15 induces interleukin‐17 production by synovial T cell lines from patients with rheumatoid arthritis. Scandinavian journal of immunology. 2011 Mar;73(3):243-9.
94. Pöllinger B, Junt T, Metzler B, Walker UA, Tyndall A, Allard C, Bay S, Keller R, Raulf F, Di Padova F, O’Reilly T. Th17 cells, not IL-17+ γδ T cells, drive arthritic bone destruction in mice and humans. The Journal of Immunology. 2011 Feb 15;186(4):2602-12.
95. Zwerina K, Koenders M, Hueber A, Marijnissen RJ, Baum W, Heiland GR, Zaiss M, Mclnnes I, Joosten L, van den Berg W, Zwerina J. Anti IL‐17A therapy inhibits bone loss in TNF‐α‐mediated murine arthritis by modulation of the T‐cell balance. European Journal of Immunology. 2012 Feb;42(2):413-23.
96. Volpe E, Servant N, Zollinger R, Bogiatzi SI, Hupé P, Barillot E, Soumelis V. A critical function for transforming growth factor-β, interleukin 23 and proinflammatory cytokines in driving and modulating human TH-17 responses. Nature immunology. 2008 Jun;9(6):650-7.
97. Adamopoulos IE, Chao CC, Geissler R, Laface D, Blumenschein W, Iwakura Y, McClanahan T, Bowman EP. Interleukin-17A upregulates receptor activator of NF-κB on osteoclast precursors. Arthritis research & therapy. 2010 Feb; 12:1-1.
98. Sato K, Suematsu A, Okamoto K, Yamaguchi A, Morishita Y, Kadono Y, Tanaka S, Kodama T, Akira S, Iwakura Y, Cua DJ. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. Journal of experimental medicine. 2006 Nov 27;203(12):2673-82.
99. Adamopoulos IE, Bowman EP. Immune regulation of bone loss by Th17 cells. Arthritis research & therapy. 2008 Oct; 10:1-9.